27 May 2020 13:10
UK TRADING UPDATE SUMMARY: Caffyns To Reopen Showrooms As Curbs Ease
UK TRADING UPDATE SUMMARY: Caffyns To Reopen Showrooms As Curbs Ease
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
VEC.L Share News (VEC)
VEC Share
Price
VEC Share
News
VEC Share
Chat
VEC Share
Trades
VEC
Live RNS
VEC Share
Charts
VEC Broker
Ratings
VEC Directors
Deals
VEC Financial
Diary
VEC
Fundamentals
VEC Short
Positions
VEC
Media
VEC.L Information
- There is currently no data for VEC
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.Thursday broker round-up
Thu, 21st May 2015 13:01
Barclays: JP Morgan Cazenove reiterates overweight and 285p target.StanChart: Goldman sachs reiterates neutral.St.James Place: Numis reiterates add and 1050p target.Hargreaves Lansdown: JP Morgan Cazenove reiterates neutral and raises target to 1,100p from 1,050p.UK Mail Group: RBC Capital reiterates outperform and and improves target to 540p from 510p.Premier Foods: SocGen raises target to 50p from 35p and hold.Marks&Spencer: Barclays reiterates equal-weight and takes target to 600p from 390p.Vectura Group: JP Morgan Cazenove reiterates overweight and raises target to 250p from 230p.HSBC: Goldman Sachs reiterates buy.GlaxoSmithKline: Citi reiterates neutral and 1,550p target.GlaxoSmithKline: Jefferies lowers target to 1,450p from 1,520p and reiterates hold.
More News
1 May 2020 14:30
Vectura upbeat on EMA nod for 'Enerzair Breezhaler'
(Sharecast News) - Inhalation contract manufacturer Vectura Group noted an announcement from Novartis on Friday, that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of 'Enerzair Breezhaler'.
Read more23 Mar 2020 09:43
UK BROKER RATINGS SUMMARY: Barclays Raises Pearson, Moneysupermarket
UK BROKER RATINGS SUMMARY: Barclays Raises Pearson, Moneysupermarket
Read more17 Mar 2020 12:31
Vectura Resilient Against Covid-19 As Flutiform Drives Annual Growth
Vectura Resilient Against Covid-19 As Flutiform Drives Annual Growth
Read more10 Mar 2020 16:03
UK Earnings, Trading Statements Calendar - Next 7 Days
UK Earnings, Trading Statements Calendar - Next 7 Days
Read more27 Jan 2020 09:36
UK BROKER RATINGS SUMMARY: Peel Hunt Cuts Ashtead And Raises DCC
UK BROKER RATINGS SUMMARY: Peel Hunt Cuts Ashtead And Raises DCC
Read more21 Jan 2020 12:48
Avacta Group Hires Vectura Group CFO Fry As Non-Executive Director
Avacta Group Hires Vectura Group CFO Fry As Non-Executive Director
Read more13 Jan 2020 09:19
Vectura Targeting New Royalties In 2020 As Glaxo Lawsuit Rumbles On
Vectura Targeting New Royalties In 2020 As Glaxo Lawsuit Rumbles On
Read more13 Jan 2020 08:25
Vectura sees FY revenues and earnings 'at least' in line with expectations
(Sharecast News) - Pharmaceuticals company Vectura said on Monday that its base business had continued to perform well in 2019.
Read more27 Nov 2019 08:26
TOP NEWS: Hikma Submits Response To Advair Application Deficiencies
TOP NEWS: Hikma Submits Response To Advair Application Deficiencies
Read more29 Oct 2019 09:41
Vectura Group Hires Former GE Healthcare Exec Will Downie As New CEO
Vectura Group Hires Former GE Healthcare Exec Will Downie As New CEO
Read more18 Oct 2019 16:06
4 Oct 2019 17:31
UPDATE 1-Vectura, Sandoz win ruling on inhaler packaging case against GSK
(Adds comment from GSK spokesman)Oct 4 (Reuters) - Vectura Group said on Friday a British court had ruled in its favour on the packaging of a generic version of an inhaler made by bigger rival GlaxoSmithKline.Vectura said the court dismissed all G...
Read more4 Oct 2019 14:24
High Court Dismisses Glaxo Case Against Generic Seretide Accuhaler
High Court Dismisses Glaxo Case Against Generic Seretide Accuhaler
Read more3 Oct 2019 16:04